43 studies found for:
"Adrenocortical carcinoma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
|
||||
| 22 | Completed |
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
|
||||
| 23 | Unknown † |
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
|
||||
| 24 | Completed |
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
|
||||
| 25 | Completed |
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
|
||||
| 26 | Active, not recruiting |
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
|
||||
| 27 | Recruiting |
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
|
||||
| 28 | Completed |
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
|
||||
| 29 | Recruiting |
Adrenal Tumors - Pathogenesis and Therapy
|
||||
| 30 | Active, not recruiting |
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
|
||||
| 31 | Completed |
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
|
||||
| 32 | Completed |
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
|
||||
| 33 | Completed |
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
|
||||
| 34 |
Completed
Has Results |
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
|
||||
| 35 | Completed |
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
|
||||
| 36 | Completed |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
|
||||
| 37 | Completed |
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
|
||||
| 38 | Recruiting |
Study of Adrenal Gland Tumors
|
||||
| 39 | Unknown † |
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
|
||||
| 40 | Completed |
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
|
† Indicates status has not been verified in more than two years

